Dartmouth-Hitchcock Medical Center

Oncology & Cancer

Researchers test safety of Nivolumab in kidney cancer

Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center will present a poster on a phase I clinical trial of Nivolumab, a PD-1 receptor blocking antibody, being used in combination with other drugs in patients with ...

page 4 from 8